Similar companies
Calidi Biotherapeutics X Follower Count
Calidi Biotherapeutics has 230 followers on X (formerly Twitter), roughly flat (+1.3%) over the past three months.
With 230 followers, Calidi Biotherapeutics has a smaller X following than industry peers like Amgen (118,653) and Gilead Sciences (72,295).
How Calidi Biotherapeutics’s X Growth Feeds the CLDI AI Score
X follower trends are particularly relevant for companies with strong direct-to-consumer brands or high-profile leadership. A follower count is not a stock price on its own, but for consumer-facing companies a sustained shift in following can reflect changing brand momentum. AltIndex feeds Calidi Biotherapeutics’s X following into the CLDI AI Score as one of 25+ alternative data signals, weighed against hiring, web traffic, sentiment, and fundamentals.
For Calidi Biotherapeutics’s reach on other platforms, see Calidi Biotherapeutics Instagram followers, TikTok followers, YouTube subscribers, and Facebook followers.
For real-time conversation volume, see CLDI X mentions. For other demand signals, see web traffic, app downloads, and Google Trends.
Month over Month
| Aug 2026 | 232 | |
| Jul 2026 | 228 | |
| Jun 2026 | 224 | |
| May 2026 | 211 | |
| Apr 2026 | 208 | |
| Mar 2026 | 210 |
Calidi Biotherapeutics X (Twitter) Followers: Frequently Asked Questions
Calidi Biotherapeutics has 230 followers (230) on X (formerly Twitter), based on AltIndex’s tracking of the company’s official X account.
Calidi Biotherapeutics's X following has been roughly flat (+1.3%) over the past three months. View the trend chart above for the full history.
X follower trends are most telling for companies with strong direct-to-consumer brands or high-profile leadership. No single data point predicts a stock on its own, but a sustained change in Calidi Biotherapeutics's following can reflect shifting public interest. That is why AltIndex combines Calidi Biotherapeutics's X following with web traffic, hiring, sentiment, and 20+ other signals in its AI Score rather than reading any one signal in isolation.
Calidi Biotherapeutics underperforms its industry peers when it comes to X Followers, ranking dead last.
With fewer than 1,000 followers, Calidi Biotherapeutics' X account is in its growth phase, focusing on building its audience. This suggests a niche but potentially dedicated following, important for targeted engagement.
Sign up and get more insights on Calidi Biotherapeutics.
See Calidi Biotherapeutics’s complete x followers history
Sign up to unlock 1-year and all-time charts for CLDI, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREE
